Dirk A. Lamprecht

1.2k total citations
15 papers, 699 citations indexed

About

Dirk A. Lamprecht is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Dirk A. Lamprecht has authored 15 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Dirk A. Lamprecht's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (9 papers) and Cancer therapeutics and mechanisms (3 papers). Dirk A. Lamprecht is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (9 papers) and Cancer therapeutics and mechanisms (3 papers). Dirk A. Lamprecht collaborates with scholars based in United States, South Africa and Belgium. Dirk A. Lamprecht's co-authors include Adrie J. C. Steyn, John Adamson, Bridgette M. Cumming, Md. Aejazur Rahman, Shannon Russell, Peter Finin, Vikram Saini, Joel N. Glasgow, Vineel P. Reddy and Krishna C. Chinta and has published in prestigious journals such as Nature Communications, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Dirk A. Lamprecht

14 papers receiving 692 citations

Peers

Countries citing papers authored by Dirk A. Lamprecht

Since Specialization

Citations

This map shows the geographic impact of Dirk A. Lamprecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk A. Lamprecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk A. Lamprecht more than expected).

Fields of papers citing papers by Dirk A. Lamprecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk A. Lamprecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk A. Lamprecht. The network helps show where Dirk A. Lamprecht may publish in the future.

Co-authorship network of co-authors of Dirk A. Lamprecht

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk A. Lamprecht. A scholar is included among the top collaborators of Dirk A. Lamprecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk A. Lamprecht. Dirk A. Lamprecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3 2025 ·PubMed ·Amit Kumar Verma, Robbert Q. Kim, Dirk A. Lamprecht, (unknown), Sarah N. P. Wong, Nicolas Véziris, Alexandra Aubry, (unknown), Rodrigo J. Carbajo, J. Denise Wetzel, Meindert H. Lamers	0
2	An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates 2024 ·Scientific Reports ·Jody Phelan, (unknown), (unknown), (unknown), (unknown), Dirk A. Lamprecht, Anil Koul, Richard J. Wall	2
3	A high-throughput target-based screening approach for the identification and assessment of Mycobacterium tuberculosis mycothione reductase inhibitors 2024 ·Microbiology Spectrum ·(unknown), (unknown), (unknown), Linda De Vooght, (unknown), (unknown), Koen Augustyns, Sergei V. Strelkov, Dirk A. Lamprecht, Koen Temmerman, Yann G.‐J. Sterckx, Davie Cappoen, Paul Cos	3
4	Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility 2021 ·Antioxidants ·(unknown), Md. Aejazur Rahman, (unknown), Jared S. Mackenzie, Vikram Saini, Dirk A. Lamprecht, John Adamson, (unknown), Jack R. Lancaster, Michael Berney, Joel N. Glasgow, Adrie J. C. Steyn	15
5	Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis 2020 ·Nature Communications ·Vikram Saini, Krishna C. Chinta, Vineel P. Reddy, Joel N. Glasgow, (unknown), Dirk A. Lamprecht, Md. Aejazur Rahman, Jared S. Mackenzie, (unknown), John Adamson, (unknown), Shannon M. Bailey, Douglas R. Moellering, Jack R. Lancaster, Adrie J. C. Steyn	76
6	New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis 2020 ·PLoS Pathogens ·Andréanne Lupien, Caroline S. Foo, Svetlana Savina, Anthony Vocat, Jérémie Piton, (unknown), Andrej Benjak, Dirk A. Lamprecht, Adrie J. C. Steyn, Kévin Pethe, Vadim Makarov, Stewart T. Cole	35
7	Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis 2020 ·Nature Communications ·Jared S. Mackenzie, Dirk A. Lamprecht, (unknown), John Adamson, Khushboo Borah, Dany J. V. Beste, Bei Shi Lee, Kévin Pethe, (unknown), Inna V. Krieger, James C. Sacchettini, Joel N. Glasgow, Adrie J. C. Steyn	47
8	Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection 2019 ·Cell Reports ·Shannon Russell, Dirk A. Lamprecht, (unknown), (unknown), Vanessa Naidoo, Kelvin W. Addicott, Chivonne Moodley, (unknown), David K. Crossman, Gordon Wells, Adrie J. C. Steyn	68
9	Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis 2018 ·mBio ·Caroline S. Foo, Andréanne Lupien, (unknown), Anthony Vocat, Andrej Benjak, (unknown), Dirk A. Lamprecht, Adrie J. C. Steyn, Kévin Pethe, Jérémie Piton, Karl‐Heinz Altmann, Stewart T. Cole	54
10	Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection 2017 ·PLoS Pathogens ·Bridgette M. Cumming, Md. Aejazur Rahman, Dirk A. Lamprecht, Kyle H. Rohde, Vikram Saini, John Adamson, David G. Russell, Adrie J. C. Steyn	32
11	Susceptibility of Mycobacterium tuberculosis Cytochrome bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c 2017 ·Antimicrobial Agents and Chemotherapy ·A. Moosa, Dirk A. Lamprecht, Kriti Arora, Clifton E. Barry, Helena I. Boshoff, Thomas R. Ioerger, Adrie J. C. Steyn, Valerie Mizrahi, Digby F. Warner	42
12	Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis 2016 ·Cell Reports ·Vikram Saini, Bridgette M. Cumming, (unknown), Dirk A. Lamprecht, John Adamson, Vineel P. Reddy, Krishna C. Chinta, (unknown), Joel N. Glasgow, Melissa Richard‐Greenblatt, Anaximandro Gómez-Velasco, Horacio Bach, Yossef Av‐Gay, Hyungjin Eoh, Kyu Y. Rhee, Adrie J. C. Steyn	114
13	Turning the respiratory flexibility of Mycobacterium tuberculosis against itself 2016 ·Nature Communications ·Dirk A. Lamprecht, Peter Finin, Md. Aejazur Rahman, Bridgette M. Cumming, Shannon Russell, (unknown), John Adamson, Adrie J. C. Steyn	175
14	The Physiology and Genetics of Oxidative Stress in Mycobacteria 2014 ·Microbiology Spectrum ·Bridgette M. Cumming, Dirk A. Lamprecht, (unknown), Vikram Saini, (unknown), Adrie J. C. Steyn	30
15	An enzyme-initiated Smiles rearrangement enables the development of an assay of MshB, the GlcNAc-Ins deacetylase of mycothiol biosynthesis 2012 ·Organic & Biomolecular Chemistry ·Dirk A. Lamprecht, (unknown), Hayden Eastwood, Kevin J. Naidoo, Erick Strauss, Anwar Jardine	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact